Results 171 to 180 of about 1,067 (186)

Orally-active, clinically-translatable senolytics restore α-Klotho in mice and humans

EBioMedicine, 2022
Yi Zhu, Nino Giorgadze, Ailing Xue
exaly  

Senolytics dasatinib and quercetin in idiopathic pulmonary fibrosis: results of a phase I, single-blind, single-center, randomized, placebo-controlled pilot trial on feasibility and tolerability

EBioMedicine, 2023
Anoop M Nambiar, Dean Kellogg
exaly  

Senolytic Drugs

2019
Valeria Conti, Teresa Iannaccone, Amelia Filippelli   +2 more
openaire   +1 more source

Fisetin: A senolytic drug

2021
Asma Shafique, Sumia Akram, Muhammad Mushtaq   +2 more
openaire   +1 more source

Senolytic drugs: Beyond the promise and the hype

Mechanisms of Ageing and Development, 2022
Diana, Jurk, João F, Passos
openaire   +2 more sources

Immune checkpoint inhibitors as senolytic agents

Cell Research, 2022
Parminder Singh, Pankaj Kapahi, Jan M. van Deursen   +2 more
openaire   +2 more sources

Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease

EBioMedicine, 2019
Latonya J Hickson, Larissa G P Langhi Prata, Shane A Bobart   +2 more
exaly  

Senolytics in idiopathic pulmonary fibrosis: Results from a first-in-human, open-label, pilot study

EBioMedicine, 2019
Jamie N Justice, Anoop M Nambiar, Tamara Tchkonia   +2 more
exaly  

Discovery, development, and future application of senolytics: theories and predictions

FEBS Journal, 2020
Erin O Wissler Gerdes, Tamara Tchkonia, James L Kirkland   +2 more
exaly  

Senolytics

Abhilasha Ahlawat, Neeta Solanki, Sachin Kumar Singh, Kamal Dua, Harish Dureja   +4 more
openaire   +1 more source